Combined fluorine-18-FDG and carbon-11-methionine PET for diagnosis of tumors in lung and mediastinum

Journal of Nuclear Medicine

Volumn 39, Issue 4, 1998, Pages 640-647

  Nettelbladt, Otto S ^a,b   Sundin, Anders E ^a   Valind, Sven O ^a   Gustafsson, Gunnar R ^a   Lamberg, Kristina ^a   Långström, Bengt ^a   Björnsson, Eythor H ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Carbon 11 methionine; Fluorine 18 fluorodeoxyglucose; Lung tumor; Mediastinal metastases; PET; Staging

Indexed keywords

CARBON 11; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMAGE ENHANCEMENT; ISOTOPE LABELING; LUNG SCINTISCANNING; LUNG TUMOR; MALE; MEDIASTINUM METASTASIS; PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; THORAX SCINTISCANNING;

AGED; CARBON RADIOISOTOPES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MEDIASTINAL NEOPLASMS; METHIONINE; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031954713     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Boring CC, Squires TS, Tang T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994;44:7-26.
2. Jaklitsch M, Strauss G, Healey E, DeCamp M, Liptay M, Sugarbaker D. An historical perspective of multi-modality treatment for resectable non-small cell lung cancer. Lung Cancer 1995;12:S17-S32.
3. Non-small CLCG. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311: 899-909.
4. Williams A, Santiago S, Lehrman S, Popper R. Transcutaneous needle aspiration of solitary pulmonary masses: how many passes? Am Rev Respir Dis 1987;136:452-454.
5. Winning A, McIvor J, Seed WA, Husain O, Metaxas N. Interpretation of negative results in fine needle aspiration of discrete pulmonary lesions. Thorax 1986;41:875-879.
6. Wang K, Kelly S, Britt J. Percutaneous needle aspiration biopsy of chest lesions. New instrument and new technique. Chest 1988;93:993-997.
7. Schenk D, Bryan C, Bower J, Myers D. Transbronchial needle aspiration in the diagnosis of bronchogenic carcinoma. Chest 1987;92:83-85.
8. Polak J, Kubik A. Percutaneous thin needle biopsy of malignant and non-malignant thoracic lesions. Radiologia Diagnostica 1989;30:177-182.
9. Webb WR. Radiologic evaluation of the solitary pulmonary nodule. Am J Roentgenol 1990;154:701-708.
10. Scott WJ, Gobar LS, Hauser LG, Sunderland JJ, Dewan NA, Sugimoto JT. Detection of scalene lymph node metastases from lung cancer. Positron emission tomography. Chest 1995;107:1174-1176.
11. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
12. Swensen SJ, Morin RL, Schueler BA, et al. Solitary pulmonary nodule: CT evaluation of enhancement with iodinated contrast material - a preliminary report. Radiology 1992;182:343-347.
13. Bragg DG. Current applications of imaging procedures in the patient with lung cancer. Int J Radiat Oncol Biol Phys 1991;21:847-851.
14. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991;32:623-648.
15. Wahl RL, Hutchins GD, Buchsbaum DJ, Liebert M, Grossman HB, Fisher S. Fluorine-18-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron emission tomography. Cancer 1991; 67:1544-1550.
16. Nolop K, Rhodes C, Brudin L, et al. Glucose utilization in vivo by human pulmonary neoplasm. Cancer 1987;60:2682-2689.
17. 18F]fluorodeoxyglucose. The members of the PET lung tumor study group. Ann Thorac Surg 1994;58:698-703.
18. 18F-2-fluoro-2-deoxy-D-glucose and positron and emission tomography: preliminary study of lung cancer. Int J Radiat Oncol Biol Phys 1990;19:1005-1010.
19. Slosman DO, Spiliopoulos A, Couson F, et al. Satellite PET and lung cancer: a prospective study in surgical patients. Nucl Med Commun 1993;14:955-961.
20. 18F-fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
21. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-F-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993;104:997 1002.
22. Fujiwara T, Matsuzawa T, Kubota K, et al. Relationship between histologic type of primary lung cancer and carbon-11-L-methionine uptake with positron emission tomography. J Nucl Med 1989;30:33-37.
23. 11C-L-methionine. J Nucl Med 1985;26:37-42.
24. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study. J Nucl Med 1990;31:1927-1932.
25. Kubota K, Yamada S, Ishiwata K, Ito M, Ido T. Positron emission tomography for treatment evaluation and recurrence detection compared with CT in long-term follow-up cases of lung cancer. Clin Nucl Med 1992;17:877-881.
26. Rhodes CG, Wollmer P, Fazio F, Jones TJ. Quantitative measurement of regional extravascular lung density using positron emission and transmission tomography. J Comput Assist Tomogr 1981;5:783-791.
27. 11C]methionine. J Nucl Med 1987;28:1037-1040.
28. 18F]Fluoro-d-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinum resin. Nucl Med Biol 1990;17:273.
29. Kops E, Herzog H, Schmid A, Holte S, Feinendegen L. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990;14:437-445.
30. Patlak C, Blasberg R, Fenstermacher J. Graphic evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cerebr Blood Flow Metab 1983;3:1-7.
31. 11C-]-methionine uptake in tumor using positron emission tomography. J Nucl Med 1989;30:1809-1813.
32. Hübner KF, Buonocore E, Singh SK, Gould HR, Cotten DW. Characterization of chest masses by F-FDG positron emission tomography. Clin Nucl Med 1995;20:293-298.
33. Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglueose. Cancer 1993;72: 82-90.
34. Dewan NA, Reeb SD, Gupta NC, Gobar LS, Scott WJ. PET-F-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis. Chest 1995;108:441-446.
35. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[Isqb]F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-382.
36. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by corrective lymph node mapping and sampling. Radiology 1991;182:319-323.
37. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with F-FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-377.